You just read:

Zacks Analyst Blog Highlights: Amylin Pharmaceuticals, Eli Lilly and Company, Alkermes, Novo Nordisk and The Dow Chemical

News provided by

Zacks Investment Research, Inc.

Mar 14, 2011, 10:04 ET